Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.09M Buy
28,288
+13,683
+94% +$3.04M 3.4% 11
2025
Q4
$2.37M Buy
+14,605
New +$2.54M 0.84% 31
2025
Q1
Sell
-8,971
Closed -$1.02M 78
2024
Q4
$1.02M Buy
+8,971
New +$1.07M 0.41% 44
2024
Q3
Sell
-17,875
Closed -$1.55M 85
2024
Q2
$1.55M Sell
17,875
-2,825
-14% -$257K 0.64% 40
2024
Q1
$1.69M Buy
20,700
+400
+2% +$25.1K 0.75% 38
2023
Q4
$975K Buy
+20,300
New +$864K 0.54% 43

Other funds holding VRT

Geneva Partners's VRT Position: Q1 2026 in Review

Geneva Partners increased its Vertiv (VRT) stake by 94% in Q1 2026, buying an estimated $3.04M and bringing the position to 28,288 shares worth $7.09M. The position accounts for 3.4% of the portfolio, ranked #11.

Geneva Partners first reported a position in VRT in Q4 2023 and has held it in 6 quarters since. 1,826 funds tracked by Wall St. Rank hold VRT as of Q1 2026.

  • Geneva Partners held 28,288 shares of Vertiv worth $7.09M as of Q1 2026.
  • Geneva Partners bought 13,683 Vertiv shares in Q1 2026, an estimated $3.04M.
  • Vertiv made up 3.4% of Geneva Partners's portfolio in Q1 2026, its #11 holding.
  • Geneva Partners first reported a position in Vertiv in Q4 2023 and has held it in 6 quarters since.
  • 1,826 funds tracked by Wall St. Rank held Vertiv as of Q1 2026.

Based on Geneva Partners's 13F filing for Q1 2026, filed 29 Apr 2026.